Published in AIDS on May 15, 2009
Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission | NCT00194519
Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda | NCT00405821
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet (2010) 4.23
Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One (2010) 2.48
Autonomous targeting of infectious superspreaders using engineered transmissible therapies. PLoS Comput Biol (2011) 1.10
The Sordid Affair Between Human Herpesvirus and HIV. J Infect Dis (2015) 1.02
Modelling sexual transmission of HIV: testing the assumptions, validating the predictions. Curr Opin HIV AIDS (2010) 1.01
The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model. Vaccine (2011) 1.00
Species-specific treatment effects of helminth/HIV-1 co-infection: a systematic review and meta-analysis. Parasitology (2011) 0.95
Time to refocus on HSV interventions for HIV prevention? J Infect Dis (2011) 0.88
Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2. PLoS One (2012) 0.85
Modelling the interactions between herpes simplex virus type 2 and HIV: implications for the HIV epidemic in southern India. Sex Transm Infect (2010) 0.80
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science (1996) 18.38
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS (2006) 10.56
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 9.17
Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med (2007) 7.79
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med (2008) 7.49
Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses (2001) 6.00
The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr (2004) 5.94
Relation between HIV viral load and infectiousness: a model-based analysis. Lancet (2008) 5.74
Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis (2007) 4.52
Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci U S A (2007) 3.29
Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis (2000) 3.21
Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One (2008) 3.05
Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS (2009) 2.97
Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS (2008) 2.91
Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J Infect Dis (2008) 2.77
Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand. J Acquir Immune Defic Syndr (2008) 2.05
AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion. AIDS (1997) 1.97
Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics. Sex Transm Infect (2007) 1.89
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis (1998) 1.88
The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation. J Biol Chem (2008) 1.83
Association between cervical shedding of herpes simplex virus and HIV-1. AIDS (2002) 1.64
Gender difference in HIV RNA levels: a meta-analysis of published studies. J Acquir Immune Defic Syndr (2002) 1.59
Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial. AIDS (2006) 1.58
Chronic herpes simplex virus type-2 infection and HIV viral load. Int J STD AIDS (2005) 1.17
A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers. Sex Transm Infect (2008) 1.16
Gender difference in HIV-1 RNA viral loads. HIV Med (2005) 1.08
The HIV RNA setpoint theory revisited. Retrovirology (2007) 1.06
Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature (2005) 30.92
Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24
Strategies for mitigating an influenza pandemic. Nature (2006) 25.20
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet (2002) 16.56
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01
Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science (2003) 12.26
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet (2003) 10.74
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS (2006) 10.56
Rapid pneumococcal evolution in response to clinical interventions. Science (2011) 9.09
Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A (2008) 8.27
Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med (2007) 7.79
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med (2008) 7.49
Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ (2009) 6.66
Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med (2009) 6.65
HIV-1 transmission, by stage of infection. J Infect Dis (2008) 6.57
The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet (2011) 5.87
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS (2010) 5.85
Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. J Infect Dis (2009) 5.73
Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med (2010) 5.71
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. Ann Intern Med (2011) 5.35
Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun (2012) 5.34
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet (2006) 5.00
Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med (2012) 4.68
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet (2010) 4.23
Male circumcision for HIV prevention: from evidence to action? AIDS (2008) 4.11
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model. BMJ (2011) 3.90
Will travel restrictions control the international spread of pandemic influenza? Nat Med (2006) 3.89
Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Med (2006) 3.86
Public health. Public health risk from the avian H5N1 influenza epidemic. Science (2004) 3.71
Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS One (2009) 3.66
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis (2011) 3.59
Biological and behavioural impact of an adolescent sexual health intervention in Tanzania: a community-randomized trial. AIDS (2007) 3.51
Fuzzy species among recombinogenic bacteria. BMC Biol (2005) 3.47
Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load? AIDS (2013) 3.36
Host immunity and synchronized epidemics of syphilis across the United States. Nature (2005) 3.34
Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med (2009) 3.31
Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci U S A (2007) 3.29
New strategies for the elimination of polio from India. Science (2006) 3.27
CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater. J Acquir Immune Defic Syndr (2007) 3.18
Evaluation of a community-based rehabilitation model for chronic schizophrenia in rural India. Br J Psychiatry (2003) 3.15
Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J (2008) 3.02
Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS (2010) 2.98
Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS (2009) 2.97
West African Ebola epidemic after one year--slowing but not yet under control. N Engl J Med (2014) 2.96
Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS One (2010) 2.90
Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med (2008) 2.78
Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect Dis (2008) 2.78
Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS (2003) 2.78
Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med (2011) 2.76
Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J (2008) 2.68
Seasonal infectious disease epidemiology. Proc Biol Sci (2006) 2.62
Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol (2004) 2.55
Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS (2008) 2.54
Hyper-recombination, diversity, and antibiotic resistance in pneumococcus. Science (2009) 2.54
Costs and cost-effectiveness of malaria control interventions--a systematic review. Malar J (2011) 2.53
Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol (2009) 2.51
Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol (2004) 2.47
Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci (2004) 2.45
The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med (2004) 2.36
Assessing the reliability of eBURST using simulated populations with known ancestry. BMC Microbiol (2007) 2.36
Mathematical models of infectious disease transmission. Nat Rev Microbiol (2008) 2.32
A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS (2008) 2.25
Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat Commun (2012) 2.17
Ebola virus disease among children in West Africa. N Engl J Med (2015) 2.17
Long-term biological and behavioural impact of an adolescent sexual health intervention in Tanzania: follow-up survey of the community-based MEMA kwa Vijana Trial. PLoS Med (2010) 2.09
Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med (2012) 2.06
Herpes simplex virus type 2: a key role in HIV incidence. AIDS (2009) 2.03
Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Health (2009) 2.01
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data. Lancet Infect Dis (2013) 2.00
Modelling the impact of vector control interventions on Anopheles gambiae population dynamics. Parasit Vectors (2011) 1.99
The impact of homologous recombination on the generation of diversity in bacteria. J Theor Biol (2005) 1.99
The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. PLoS One (2011) 1.95
A new framework and software to estimate time-varying reproduction numbers during epidemics. Am J Epidemiol (2013) 1.94
The importance of mosquito behavioural adaptations to malaria control in Africa. Evolution (2013) 1.93
Sequences, sequence clusters and bacterial species. Philos Trans R Soc Lond B Biol Sci (2006) 1.91